← back to database
Santé Ventures invests in US healthcare companies across biotechnology, medical technology and digitally enabled health services. It typically enters at Seed, Series A or Series B, often leads or co-leads, invests $5 million–$8 million initially and can invest up to $25 million over the partnership.
Stage focus
Lead / follow
Check size
Ownership target
Specialization
Generalist / Specialist
Specialist
Latest fund size
$330 million Fund V; more than $1 billion managed across five funds
Latest fund vintage
2026
Investing team
- Alana HorowitzSenior Associate
- Auriel AugustPrincipal
- Casey CunninghamPartner & Chief Scientific Officer
- Dennis McWilliamsManaging Director
- Douglas FrenchFounding Managing Director
- James EadieManaging Director
- Joe CunninghamFounding Managing Director
- Kevin LalandeFounding Managing Director & Chief Investment Officer
- Kyle SchroederSenior Analyst
- Mateo VargasSenior Associate
- Michael GutbrodPrincipal
- Omar KhalilManaging Director
- Ryan HallAssociate